Pulse Biosciences, Inc. Appoints Maria Sainz to Board of Directors Effective January 9, 2026

Pulse Biosciences, Inc. appointed Maria Sainz to its Board of Directors effective January 9, 2026.135

Maria Sainz has over 30 years in healthcare technology, including 18 years as CEO of public and venture-backed companies like Hyperfine, Inc., Aegea Medical, and CardioKinetix.12

She previously held leadership roles at Guidant Corporation and Boston Scientific Corporation.1

Sainz serves or has served on boards including Shockwave Medical, Spectranetics Corp, Avanos Medical, Orthofix Medical Inc., and Hyperfine.12

Her expertise is expected to accelerate commercialization of Pulse's nPulse™ nsPFA technology, aiding regulatory, market access, and expansion into cardiac ablation and oncology.2

Sources:

1. https://www.marketscreener.com/news/pulse-biosciences-inc-appoints-maria-sainz-to-its-board-of-directors-effective-january-9-2026-ce7e59d3d881ff23

2. https://www.ainvest.com/news/maria-sainz-strategic-addition-pulse-biosciences-board-implications-npulse-commercialization-2601/

3. https://ng.investing.com/news/company-news/pulse-biosciences-appoints-healthcare-veteran-maria-sainz-to-board-93CH-2282351

5. https://www.streetinsider.com/Board+Changes/Pulse+Biosciences+names+Maria+Sainz+to+board+of+directors/25829067.html